The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.

In that single-arm study, the rate of primary adverse events within 7 days of ablation was 2.9%, with the most common ...

Esophageal squamous cell carcinoma (ESCC) is a severe health threat, being a predominant subtype of esophageal cancer and ...

Looking back, Kokomo resident Mike Beatty knew he had something as a teenager, but he couldn’t put a name to it.

The long-term safety of ibrutinib was proven in patients with newly diagnosed or relapsed or refractory (R/R) chronic ...

Pulsed field ablation (PFA) is emerging as an alternative, using non-thermal electric fields to target cardiac tissue while ...

THRV-1268 is under clinical development by Thryv Therapeutics and currently in Phase I for Atrial Fibrillation.

Dofetilide is under clinical development by Hyloris Pharmaceuticals and currently in Phase I for Atrial Flutter.

About 200,000 Louisiana residents are living with a heart condition called atrial fibrillation but there is a new treatment ...

The temporary pause will allow the company to investigate four neurovascular events seen in an external validation study.

These days, Beatty takes medications to help control his Afib ... And what exactly is atrial fibrillation anyway? To answer those questions, CNHI News Indiana reached out to Dr. Anil Ranginani ...